Insight Molecular Diagnostics Inc.
Ownership
Ownership Structure
Who owns Insight Molecular Diagnostics Inc. (IMDX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 31.8% of the shares are freely tradable; institutional investors hold 61.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BROADWOOD CAPITAL Inc | 38.76 | 12,684,884 | +6.3 | 06/30/2026 |
| Awm Investment Company Inc | 8.58 | 2,806,256 | -0.3 | 03/31/2026 |
| Alyeska Investment Group, L.P. | 2.57 | 840,777 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 1.64 | 537,161 | +0.0 | 03/31/2026 |
| PURA VIDA INVESTMENTS, LLC | 1.48 | 484,845 | -48.8 | 06/30/2026 |
| Heights Capital Management Inc | 1.20 | 392,545 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.80 | 262,053 | +13.5 | 03/31/2026 |
| FNY Investment Advisers, LLC | 0.76 | 247,421 | +509.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.45 | 475,405 | +0.0 | 07/31/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.76 | 248,059 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Broadwood Partners, L.P. | Major Shareholder | Buy | 40,690 | 3.88 | 157,877 |
| Apr 17, 2026 | Broadwood Partners, L.P. | Major Shareholder | Buy | 40,114 | 3.57 | 143,207 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.